Cell biology of the osteoclast

Baron, 1986, Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts, Am J Pathol, 121, 363

Burger, 1982, In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes, J Exp Med, 156, 1604, 10.1084/jem.156.6.1604

Kurihara, 1990, Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures, Endocrinology, 126, 2733, 10.1210/endo-126-5-2733

Matsuzaki, 1998, Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures, Biochem Biophys Res Comm, 246, 199, 10.1006/bbrc.1998.8586

Lee, 1995, Expression of the calcitonin receptor in bone marrow cell cultures and in bone, Endocrinology, 136, 4572, 10.1210/endo.136.10.7664679

Wada, 1995, Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells, Endocrinology, 136, 2611, 10.1210/endo.136.6.7750484

Ikegame, 1995, Calcitonin receptor isoforms in mouse and rat osteoclasts, J Bone Miner Res, 10, 59, 10.1002/jbmr.5650100110

Kukita, 1989, Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts, Lab Invest, 60, 532

Wesolowski, 1995, Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells, Exp Cell Res, 219, 679, 10.1006/excr.1995.1279

Osdoby, 1982, lsolated osteoclasts and their presumed progenitor cells, the monocyte, in culture, J Exp Zool, 224, 331, 10.1002/jez.1402240306

Zambonin-Zallone, 1982, Isolated osteoclasts in primary culture, Anat Embryol, 165, 405, 10.1007/BF00305576

Tezuka, 1994, Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts, J Biol Chem, 269, 1106, 10.1016/S0021-9258(17)42227-7

Uy, 1995, Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage, J Bone Miner Res, 10, 295, 10.1002/jbmr.5650100217

Testa, 1981, Generation of osteoclasts in vitro, J Cell Sci, 44, 127, 10.1242/jcs.47.1.127

lbbotson, 1984, ldentification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells, J Cell Biol, 94, 471, 10.1083/jcb.99.2.471

Takahashi, 1988, Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures, Endocrinology, 122, 1373, 10.1210/endo-122-4-1373

Roodman, 1985, 1,25-(OH)2 vitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow, Proc Natl Acad Sci U S A, 82, 8213, 10.1073/pnas.82.23.8213

MacDonald, 1987, Formation of multinucleated cells that respond to osteotropic hormones in long-term human bone marrow cultures, Endocrinology, 120, 2326, 10.1210/endo-120-6-2326

Thavarajah, 1991, 1,25(OH)2D3 induces differentiation of osteoclast-like cells from human bone marrow cultures, Biochem Biophys Res Commun, 176, 1189, 10.1016/0006-291X(91)90411-Y

Kassem, 1991, Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures, APMIS, 99, 262, 10.1111/j.1699-0463.1991.tb05148.x

Udagawa, 1989, The bone marrow derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells, Endocrinology, 125, 1805, 10.1210/endo-125-4-1805

Akatsu, 1992, Preparation and characterization of a mouse osteoclast-like multinucleated cell population, J Bone Miner Res, 7, 1297, 10.1002/jbmr.5650071109

Tamura, 1993, New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro, J Bone Miner Res, 8, 953, 10.1002/jbmr.5650080808

Hentunen, 1998, Development of an osteoclast cell line by targeting of bcl-XL and Simian Virus 40 large T antigen to the osteoclast lineage in transgenic mice, J Clin Invest, 102, 88, 10.1172/JCI2004

Chen, 1998, Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen, J Bone Miner Res, 13, 1112, 10.1359/jbmr.1998.13.7.1112

Takahashi, 1988, Osteoblastic cells are involved in osteoclast formation, Endocrinology, 123, 2600, 10.1210/endo-123-5-2600

Matsumoto, 1995, Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis, Endocrinology, 136, 4084, 10.1210/endo.136.9.7544276

Kodama, 1991, Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells, J Exp Med, 173, 1291, 10.1084/jem.173.5.1291

Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X

Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci U S A, 95, 3597, 10.1073/pnas.95.7.3597

Hofbauer, 1998, Osteoprotegerin and its cognate ligand, Eur J Endo, 139, 152, 10.1530/eje.0.1390152

Tsukii, 1998, Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone, Biochem Biophys Res Comm, 246, 337, 10.1006/bbrc.1998.8610

Simonet, 1997, Osteoprotegerin, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3

Yasuda, 1998, Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG), Endrocrinology, 139, 1329, 10.1210/endo.139.3.5837

Mizuno, 1998, Severe osteoporosis in mice lacking osteoblastogenesis inhibitory factor osteoprotegerin, Biochem Biophys Res Commun, 247, 610, 10.1006/bbrc.1998.8697

Gowen, 1983, Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture, Biochem Biophys Acta, 762, 471, 10.1016/0167-4889(83)90014-9

Pfeilschifter, 1989, Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro, J Bone Miner Res, 4, 113, 10.1002/jbmr.5650040116

Fried, 1989, Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha, Endocrinology, 125, 742, 10.1210/endo-125-2-742

Sato, 1989, Parathyroid hormone-related protein and interleukin-1α synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo, Endocrinology, 124, 2172, 10.1210/endo-124-5-2172

Kawano, 1989, Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma, Blood, 73, 2145, 10.1182/blood.V73.8.2145.2145

Cozzolino, 1989, Production of interleukin-1 by bone marrow myeloma cells, Blood, 74, 380, 10.1182/blood.V74.1.380.380

Yoshida, 1990, The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene, Nature, 345, 442, 10.1038/345442a0

Sundquist, 1995, Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice, Bone, 16, 39, 10.1016/8756-3282(95)80009-F

Nilsson, 1995, Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse, Blood, 86, 66, 10.1182/blood.V86.1.66.bloodjournal86166

Weir, 1993, Macrophage colony-stimulating factor release and receptor expression in bone cells, J Bone Miner Res, 8, 1507, 10.1002/jbmr.5650081214

Fuller, 1993, Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts, J Exp Med, 178, 1733, 10.1084/jem.178.5.1733

Yates, 1992, Expression of human transforming growth factor α by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption, J Bone Miner Res, 7, 847, 10.1002/jbmr.5650070715

Takahashi, 1986, Recombinant human transforming growth factor-α stimulates the formation of osteoclast-like cells in long-term human marrow cultures, J Clin Invest, 78, 894, 10.1172/JCI112677

Thomson, 1986, Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts, J Exp Med, 164, 104, 10.1084/jem.164.1.104

Thomson, 1987, Tumor necrosis factors alpha and beta induce osteoclastic cells to stimulate osteoclastic bone resorption, J Immunol, 138, 775, 10.4049/jimmunol.138.3.775

Garrett, 1987, Production of the bone-resorbing cytokine lymphotoxin by cultured human myeloma cells, N Engl J Med, 317, 526, 10.1056/NEJM198708273170902

Alsina, 1996, Development of an in vivo model of human multiple myeloma bone disease, Blood, 87, 1495, 10.1182/blood.V87.4.1495.bloodjournal8741495

Yoneda, 1991, Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice, J Clin Invest, 87, 977, 10.1172/JCI115106

Lowik, 1989, Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells, Biochemic Biophys Res Commun, 162, 1546, 10.1016/0006-291X(89)90851-6

Kurihara, 1990, IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release, J Immunol, 144, 4226, 10.4049/jimmunol.144.11.4226

De La Mata, 1995, IL-6 enhances hypercalcemia and bone resorption mediated by PTH-rP in vivo, J Clin Invest, 95, 2846, 10.1172/JCI117990

Tamura, 1993, Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6, Proc Natl Acad Sci U S A, 90, 11924, 10.1073/pnas.90.24.11924

Ohsaki, 1992, Evidence for an autocrine/paracrine role for IL-6 in bone resorption by giant cell tumors of bone, Endocrinology, 131, 2229, 10.1210/endo.131.5.1425421

Roodman, 1992, Interleukin-6, J Clin Invest, 89, 46, 10.1172/JCI115584

Paul, 1990, Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine, Proc Natl Acad Sci U S A, 87, 7512, 10.1073/pnas.87.19.7512

Girasole, 1994, Interleukin-11, J Clin Invest, 93, 1516, 10.1172/JCI117130

Mundy, 1991, The effects of TGF-beta on bone, Ciba Foundation Suppl, 157, 137

Dieudonne, 1991, Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures, J Bone Miner Res, 6, 479, 10.1002/jbmr.5650060509

Chenu, 1988, Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures, Proc Natl Acad Sci U S A, 85, 5683, 10.1073/pnas.85.15.5683

Ikeda, 1993, Ovariectomy decreases the mRNA levels of transforming growth factor-beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo, Biochem Biophys Res Commun, 194, 1228, 10.1006/bbrc.1993.1954

Pfeilschifter, 1987, Modulation of transforming growth factor β activity in bone cultures by osteotropic hormones, Proc Natl Acad Sci U S A, 84, 2024, 10.1073/pnas.84.7.2024

Gowen, 1986, Actions of recombinant interleukin-1, interleukin-2, and interferon gamma on bone resorption in vitro, J Immunol, 136, 2478, 10.4049/jimmunol.136.7.2478

Takahashi, 1986, Recombinant human gamma interferon inhibits formation of osteoclast like cells by inhibiting fusion of their precursors, J Immunol, 137, 3544, 10.4049/jimmunol.137.11.3544

Tohkin, 1994, Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK), Cancer Immunol Immunother, 39, 155, 10.1007/BF01533380

Shioi, 1991, Interleukin-4 inhibits murine osteoclast formation in vitro, J Cell Biol, 47, 272

Watanabe, 1990, Interleukin-4 as a potent inhibitor of bone resorption, Biochem Biophys Res Commun, 172, 1035, 10.1016/0006-291X(90)91550-C

Riancho, 1993, Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures, Biochem Biophys Res Commun, 196, 678, 10.1006/bbrc.1993.2303

Nakano, 1994, Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice, J Bone Miner Res, 9, 1533, 10.1002/jbmr.5650091005

Lewis, 1993, Osteoporosis induced in mice by overproduction of interleukin 4, Proc Natl Acad Sci U S A, 90, 11618, 10.1073/pnas.90.24.11618

Brandi, 1995, Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms, Proc Natl Acad Sci U S A, 92, 2954, 10.1073/pnas.92.7.2954

Lowik, 1994, lnducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption, J Clin Invest, 93, 1465, 10.1172/JCI117124

Oursler, 1994, Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells, Proc Natl Acad Sci U S A, 91, 5227, 10.1073/pnas.91.12.5227

Oursler, 1991, Avian osteoclasts as estrogen target cells, Proc Natl Acad Sci U S A, 88, 6613, 10.1073/pnas.88.15.6613

Horwood, 1998, Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor, J Clin Invest, 101, 595, 10.1172/JCI1333

Hakeda, 1998, Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts, Biochem Biophys Res Commun, 251, 796, 10.1006/bbrc.1998.9523

Menaa, 1997, Increased sensitivity to 1,25-(OH)2D3 of osteoclast precursors in Paget's disease is not due to differences in expression levels of the 1,25-D3 receptor, J Bone Miner Res, 12, S330

Abe, 1989, A synthetic analogue of vitamin D3, 22-oxa-1 alpha, 25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice, Endocrinology, 124, 2645, 10.1210/endo-124-5-2645

Feyen, 1989, Interleukin-6 is produced by bone and modulated by parathyroid hormone, J Bone Miner Res, 4, 633, 10.1002/jbmr.5650040422

Uy, 1995, Effects of PTHrP and PTH on osteoclasts and osteoclast precursors in vivo, Endocrinology, 36, 3207, 10.1210/endo.136.8.7628353

Rodan, 1981, Role of osteoblasts in hormonal control of bone resorption, Calcif Tissue lnt, 33, 349, 10.1007/BF02409454

McSheehy, 1986, Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone, Endocrinology, 118, 824, 10.1210/endo-118-2-824

Lee, 1995, Expression of the calcitonin receptor in bone marrow cell cultures and in bone, Endocrinology, 136, 4572, 10.1210/endo.136.10.7664679

Takahashi, 1995, Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation, J Clin Invest, 95, 167, 10.1172/JCI117634

Gorn, 1995, Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction, J Clin Invest, 95, 2680, 10.1172/JCI117970

Wada, 1997, Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts, Endocrinology, 138, 521, 10.1210/endo.138.2.4905

Chenu, 1990, Prostaglandin E2 inhibits formation of osteoclast-like cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor-β, J Bone Miner Res, 5, 677, 10.1002/jbmr.5650050703

Quinn, 1997, Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation, Calcif Tissue Int, 60, 63, 10.1007/s002239900187

Gallwitz, 1993, 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices, J Biol Chem, 268, 10087, 10.1016/S0021-9258(18)82175-5

Oursler, 1994, Osteoclast synthesis, secretion and activation of latent transforming growth factor beta, J Bone Miner Res, 9, 443, 10.1002/jbmr.5650090402

Takahashi, 1994, Cloning and identification of Annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption, J Biol Chem, 269, 28696, 10.1016/S0021-9258(19)61961-7

Menaa, 1999, Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures, J Clin Invest, in press

Nesbitt, 1995, Osteoclast annexins bind collagen and play a role in bone resorption, J Bone Miner Res, 10, S279

Reddy, 1995, Cloning and characterization of a novel autocrine osteoclast stimulating factor (OSF), J Bone Miner Res, 10, S325

Bartkiewicz, 1995, Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit, Gene, 160, 157, 10.1016/0378-1119(95)00228-X

Blair, 1989, Osteoclastic bone resorption by a polarized vacuolar proton pump, Science, 245, 855, 10.1126/science.2528207

Choi, 1998, Cloning and characterization of a novel inhibitor of osteoclast formation and bone resorption, J Bone Miner Res, 102, 1360

Choi, 1997, Cloning and identification of a novel inhibitor of osteoclast formation and bone resorption derived from an osteoclast library, J Bone Miner Res, 12, S157

Grigoriadis, 1994, c-Fos, Science, 266, 443, 10.1126/science.7939685

Wagner, 1998, Fos proteins in bone cell differentiation and development, Bone, 22, 35S

Owens, 1997, Fra-l stimulates osteoclastic differentiation and function in bipotential osteoclast-macrophage precursors, J Bone Miner Res, 12, S108

Franzoso, 1997, Targeted disruption of the p50 and p52 subunits of NF-κB transcription factor leads to failure of osteoclast formation and osteopetrosis, J Bone Miner Res, 12, S136

Soriano, 1991, Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice, Cell, 64, 693, 10.1016/0092-8674(91)90499-O

Boyce, 1992, Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice, J Clin Invest, 90, 1622, 10.1172/JCI116032

Lowe, 1993, Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts, Proc Natl Acad Sci U S A, 90, 4485, 10.1073/pnas.90.10.4485

Schwartzberg, 1997, Rescue of osteoclast function by transgenic expression of kinase-deficient src in src-1-mutant mice, Genes Dev, 11, 2835, 10.1101/gad.11.21.2835

Abu-Amer, 1997, Substrate recognition by osteoclast precursors induces c-src/microtubule association, J Cell Biol, 137, 247, 10.1083/jcb.137.1.247

Tanaka, 1996, C-cbl is downstream of -src in a signalling pathway necessary for bone resorption, Nature, 383, 528, 10.1038/383528a0

Anderson, 1986, Humoral and ionic regulation of osteoclast acidity, Calcif Tissue Int, 39, 252, 10.1007/BF02555214

Fallon, 1984, Alterations in the pH of osteoclast resorbing fluid reflects changes in bone degradative activity, Calcif Tissue Int, 36, 458

Anderson, 1982, Ultrastructural immunocytochemical localization of carbonic anhydrase in normal and calcitonin treated chick osteoclasts, Anat Record, 204, 9, 10.1002/ar.1092040103

Sly, 1985, Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification, N Engl J Med, 313, 139, 10.1056/NEJM198507183130302

Minkin, 1972, Carbonic anhydrase and bone remodeling, Science, 176, 1031, 10.1126/science.176.4038.1031

Hughes, 1996, Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta, Nature Med, 2, 1132, 10.1038/nm1096-1132

Bursch, 1992, Transforming growth factor β1 as a signal for induction of cell death by apoptosis, Br J Cancer, 67, 531, 10.1038/bjc.1993.98

Hughes, 1995, Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo, J Bone Miner Res, 10, 1478, 10.1002/jbmr.5650101008